Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial Results
Thursday, April 23, 2026 1 min read
Key Takeaway: Vir Biotechnology, Inc. will host a conference call on May 6, 2026, at 4:30 p.m. ET to discuss its financial results for the first quarter ending March 31, 2026. The call will provide a corporate update and can be accessed via the company's website. Vir is focused on developing treatments for infectious diseases and cancer.
Market Sentiment Analysis
POSITIVE FACTORS
Vir Biotechnology is actively engaging with investors through a conference call.
The company is focused on innovative treatments for serious diseases.
Vir has a diverse clinical-stage portfolio addressing significant health issues.
Full Press Release Details
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that it will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT on Wednesday, May 6 to provide a corporate update and discuss its financial results for the first quarter ended March 31, 2026. The conference call may be accessed on theEvents & Presentationspage of the Vir Biotechnology website.
About Vir Biotechnology
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN®dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Vir Biotechnology routinely posts information that may be important to investors on its website.
Vir Biotechnology retains exclusive rights to the PRO-XTEN®masking platform for oncology and infectious disease. PRO-XTEN®is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company.
Frequently Asked Questions
When is Vir Biotechnology's conference call?
The conference call is scheduled for May 6, 2026, at 4:30 p.m. ET.
What will be discussed in the conference call?
The call will cover Vir's financial results for the first quarter of 2026.
How can I access the conference call?
The conference call can be accessed on the Events & Presentations page of Vir's website.
What is Vir Biotechnology focused on?
Vir Biotechnology focuses on developing treatments for infectious diseases and cancer.